Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
685.8 INR | +0.69% | +2.08% | +25.73% |
Apr. 17 | Jubilant Pharmova Unit Gets VAI Status for Roorkee, India Facility | MT |
Feb. 02 | India's Jubilant Pharmova posts quarterly profit | RE |
Sales 2022 | 61.3B 735M | Sales 2023 | 62.82B 754M | Capitalization | 44.42B 533M |
---|---|---|---|---|---|
Net income 2022 | 4.14B 49.66M | Net income 2023 | -610M -7.32M | EV / Sales 2022 | 1.37 x |
Net Debt 2022 | 22.03B 264M | Net Debt 2023 | 26.44B 317M | EV / Sales 2023 | 1.13 x |
P/E ratio 2022 |
14.9
x | P/E ratio 2023 |
-72.8
x | Employees | 5,778 |
Yield 2022 |
1.29% | Yield 2023 |
1.79% | Free-Float | 36.33% |
1 day | +0.69% | ||
1 week | +2.08% | ||
Current month | +20.34% | ||
1 month | +20.95% | ||
3 months | +28.13% | ||
6 months | +91.30% | ||
Current year | +25.73% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 46 | 17-05-22 | |
Chief Executive Officer | 37 | 17-05-22 | |
Arvind Chokhany
DFI | Director of Finance/CFO | 52 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 81-12-31 | |
Chairman | 71 | 78-06-20 | |
Chief Executive Officer | 46 | 17-05-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 685.8 | +0.69% | 144 727 |
24-04-22 | 681.1 | +2.42% | 590,601 |
24-04-19 | 665 | -5.09% | 1,015,524 |
24-04-18 | 700.7 | +4.30% | 2,364,472 |
24-04-16 | 671.8 | +3.23% | 796,703 |
Delayed Quote NSE India S.E., April 23, 2024 at 02:59 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+25.46% | 659B | |
+25.38% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.13% | 215B | |
+2.93% | 210B | |
-7.65% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- JUBLPHARMA Stock
- JUBLPHARMA Stock